Biogen Pharmachem Industries Ltd — Insider Trading, 20-12-2025: Insider Trading / SAST

Biogen Pharmachem Industries has announced the closure of its trading window for company securities, effective January 1, 2026. This restriction will remain in place until 48 hours after the financial results for the quarter ended December 31, 2025, are declared. The company will soon announce the date for its board meeting to consider these financial results. This move ensures fair trading practices ahead of the earnings release, impacting how insiders can trade company shares.